DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
6.05
0.04 (0.67%)
At close: Aug 15, 2025, 2:51 PM
DiaMedica Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for DMAC stock have an median target of 11.5, with a low estimate of 6 and a high estimate of 14. The median target predicts an increase of 90.08% from the current stock price of 6.05.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 6 | 10.75 | 11.5 | 14 |
| Change | -0.83% | 77.69% | 90.08% | 131.40% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on DiaM... Unlock content with Pro Subscription
Updated Jul 18, 2025
| Rating | Oct 24 | Nov 24 | Mar 25 | May 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 0 | 3 | 0 |
| Buy | 2 | 1 | 0 | 1 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 3 | 1 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
54M
from 0
Increased by n/a%
EPS This Year
-0.71
from -0.6
Increased by -18.3%
EPS Next Year
-0.83
from -0.71
Increased by -16.9%